The CEO Roundtable on Cancer and its independent, not-for-profit initiative, Project Data Sphere® LLC, are proud to announce the approval of new ICD-10-CM diagnosis codes for immune-related adverse events (irAEs) in the United States. These codes, set to be implemented [...]
The CEO Roundtable on Cancer has awarded its Robert A. Ingram Spirit of Health Award to Gail Stephens, vice president of Health and Life Sciences at SAS, for her commitment to the fight against cancer. The award was presented at [...]
The CEO Roundtable on Cancer hosted its inaugural Partnership Summit at the global headquarters of SAS in Cary, North Carolina on Feb. 29 and March 1. The summit, a gathering of cancer experts from industry, nonprofits, academia and government, [...]
The CEO Roundtable on Cancer (CEORT) announced today the appointment of Sean Khozin, MD, MPH, as its next chief executive officer. A distinguished leader with senior executive experience in government and the private sector, including pivotal roles at the U.S. [...]
The CEO Roundtable on Cancer announced today that the University of North Carolina Pembroke and the University of Texas Permian Basin have joined its Going for Gold initiative. Going for Gold extends the Roundtable’s CEO Cancer Gold Standard® employer accreditation to minority-serving universities that [...]
The CEO Roundtable on Cancer announced today that Peter Guenter has been unanimously elected to its Board of Directors. Guenter is a member of the Executive Board of Merck KGaA and CEO of Healthcare. He joined Merck in January 2021. [...]
The National Minority Quality Forum (NMQF) and CEO Roundtable on Cancer (CEORT) held a crucial press conference today in the nation’s capital unveiling a comprehensive report submitted to the Cancer Moonshot team at the White House Office of Technology. The report, entitled "Cancer Moonshot, [...]
In a pivotal stride toward advancing cancer care, Qure.ai, a leader in artificial intelligence (AI) solutions for medical imaging, and Project Data Sphere®, a nonprofit initiative of the CEO Roundtable on Cancer, have announced their partnership to augment tumor assessments using AI-enabled [...]
Two new companies have joined the CEO Roundtable on Cancer and its campaign to improve cancer prevention, diagnosis, and treatment for their employees, their families, and their communities. Brand Institute, a global leader in brand name and corporate identity development, [...]
The CEO Roundtable on Cancer has recognized two institutions of higher education with its CEO Cancer Gold Standard® accreditation. The schools, Southern University Law Center (SULC) in Baton Rouge, Louisiana, and Winston-Salem State University (WSSU) in Winston-Salem, North Carolina, join [...]
Nonprofit research institute RTI International has joined the CEO Roundtable on Cancer in its mission to eliminate cancer as a personal disease and public health problem. “RTI’s decades of research experience will be a tremendous asset to the CEO Roundtable as we look for [...]
The CEO Roundtable on Cancer announced today that William C. Louv, PhD, will step down as the organization’s chief executive officer on Dec. 31, 2023. A search is underway to find a successor. Louv has served as CEO of the [...]
The CEO Roundtable on Cancer (CEORT) and the National Minority Quality Forum (NMQF) are joining forces to bring President Biden’s Cancer Moonshot to communities that have been marginalized by discrimination and poverty through the Cancer Stage Shifting Initiative (CSSI). CSSI is envisioned as a public/private collaboration [...]
Representatives from universities around the country gathered to discuss how to reduce the burden of cancer at their institutions and in their communities.
Going for Gold is intended to reduce disparities in cancer diagnoses and deaths among minority populations in the United States.
Joya Delgado Harris, of the CEO Roundtable on Cancer, briefed the White House Cancer Moonshot on disparities in cancer care for vulnerable and historically disenfranchised communities at a meeting in Washington, D.C. on April 19.
Sharpless also served as acting commissioner of the U.S. Food and Drug Administration and director of UNC-Chapel Hill's Lineberger Cancer Center.
It is with profound sadness that the CEO Roundtable on Cancer announces the death of its founding chairman, Robert A. Ingram.